Simple detection of point mutations associated with HIV-1 drug resistance

Journal of Virological Methods

Volumn 93, Issue 1-2, 2001, Pages 145-156

  Frater, Alexander J ^a   Chaput, Cecile C ^a   Beddows, Simon ^a   Weber, Jonathan N ^a   McClure, Myra O ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Diagnostic tests; Drug resistance; HIV; Subtypes

Indexed keywords

ANTIRETROVIRUS AGENT; NELFINAVIR; NEVIRAPINE; PROTEINASE; PROTEINASE INHIBITOR; VIRUS RNA; ZIDOVUDINE;

AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA TEMPLATE; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS MUTATION; VIRUS STRAIN; VIRUS TYPING;

AFRICA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HIV INFECTIONS; HIV-1; HUMANS; POINT MUTATION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035051027     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(01)00266-X     Document Type: Article

References (29)

1. Selection of the K103N Nevirapine (NVP) resistance mutation in Ugandan women receiving NVP prophylaxis to prevent HIV-1 vertical transmission (HIVNET-006)
2. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy
3. Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors
4. Rapid diagnosis of beta-thalassaemia by mutagenically separated polymerase chain reaction (MS-PCR) and its application to prenatal diagnosis
5. Distinct biological and serological properties of human immunodeficiency viruses from the brain
6. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor
7. Comparison of selective polymerase chain reaction primers and differential probe hybridization of polymerase chain reaction products for determination of relative amounts of codon 215 mutant and wild-type HIV-1 populations
8. HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations
9. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS
10. HIV-1 genetic subtypes and antiretroviral resistance testing
11. The role of mononuclear phagocytes in HTLV-III/LAV infection
12. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes
13. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
14. Drug resistance in HIV-infected Ugandans treated with antiretrovirals
15. Mutational analysis of residue 190 of human immunodeficiency virus type 1 reverse transcriptase
16. Effects of primer-template mismatches on the polymerase chain reaction: Human immunodeficiency virus type 1 model studies
17. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS
18. A rapid non-invasive method for the detection of the haemochromatosis C282Y mutation
19. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
20. Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction
21. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
22. Mutagenically separated PCR (MS-PCR): A highly specific one step procedure for easy mutation detection
23. Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)
24. Second worldwide evaluation of HIV-1 drug resistance genotyping quality using the ENVA 2 panel
25. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers
26. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase
27. Combination of mutations in human immunodeficiency virus type 1 reverse transcriptase required for resistance to the carbocyclic nucleoside 1592U89
28. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms
29. Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV drug access initiative-Uganda